Synthesis of 2-(4-substitutedmethylpiperazin-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides and their positive inotropic evaluation

被引:7
作者
Liu, Xue-Kun [1 ]
Cui, Xun [2 ]
Hong, Lan [2 ]
Sun, Liang-Peng [1 ]
Quan, Zhe-Shan [1 ]
Piao, Hu-Ri [1 ]
机构
[1] Yanbian Univ, Coll Pharm, Minist Educ, Key Lab Nat Resources & Funct Mol Changbai Mt, Yanji 133000, Jilin Province, Peoples R China
[2] Yanbian Univ, Coll Med, Yanji 133000, Jilin Province, Peoples R China
基金
中国国家自然科学基金;
关键词
3,4-Dihydro-3-oxo-2H-benzo[b][1,4]oxazine; Positive inotropic activity; Stroke volume; SEVERE HEART-FAILURE; MORTALITY; VESNARINONE; ATRIA;
D O I
10.1016/j.ejmech.2008.08.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In an attempt to search for more potent positive inotropic agents, a series of 2-(4-substitutedmethylpiperazin-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides were synthesized and their positive inotropic activities were evaluated by measuring left atrium stroke volume on isolated rabbit heart preparations. Several compounds showed favorable activities compared with the standard drug, milrinone, among which 2-(4-(4-methylbenzyl)piperazin-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl) acetamide 4e showed the most potent activity with the 5.09 +/- 0.00% increased stroke volume (milrinone 1.67 +/- 0.64%) at a concentration of 1 X 10(-5) M in our in vitro study. The chronotropic effects of those compounds having significant inotropic effects were also evaluated in this work. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:3027 / 3031
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 1999, CHIN J MED CHEM
[2]  
CHO KW, 1995, AM J PHYSIOL-REG I, V268, pR1129
[3]   A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure [J].
Cohn, JN ;
Goldstein, SO ;
Greenberg, BH ;
Lorell, BH ;
Bourge, RC ;
Jaski, BE ;
Gottlieb, SO ;
McGrew, F ;
DeMets, DL ;
White, BG .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (25) :1810-1816
[4]   Protein kinase-dependent and Ca2+-independent cAMP inhibition of ANP release in beating rabbit atria [J].
Cui, X ;
Wen, JF ;
Jin, JY ;
Xu, WX ;
Kim, SZ ;
Kim, SH ;
Lee, HS ;
Cho, KW .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 282 (05) :R1477-R1489
[5]  
FEDMAN MD, 1996, CIRCULATION, V93, P474
[6]   New therapies in acute decompensated heart failure [J].
Gauthier, Nadine ;
Anselm, Anjali H. ;
Haddad, Haissam .
CURRENT OPINION IN CARDIOLOGY, 2008, 23 (02) :134-140
[7]  
Harada K, 2005, INT J ONCOL, V27, P1489
[8]   C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling [J].
Lee, SJ ;
Kim, SZ ;
Cui, X ;
Kim, SH ;
Lee, KS ;
Chung, YJ ;
Cho, KW .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (01) :H208-H221
[9]  
Liao X.C., 1993, CHIN J PHARM, V1, P21
[10]   EFFECT OF ORAL MILRINONE ON MORTALITY IN SEVERE CHRONIC HEART-FAILURE [J].
PACKER, M ;
CARVER, JR ;
RODEHEFFER, RJ ;
IVANHOE, RJ ;
DIBIANCO, R ;
ZELDIS, SM ;
HENDRIX, GH ;
BOMMER, WJ ;
ELKAYAM, U ;
KUKIN, ML ;
MALLIS, GI ;
SOLLANO, JA ;
SHANNON, J ;
TANDON, PK ;
DEMETS, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1468-1475